2006 Releases

Side-Effects Evaluated in Innovative Treatment for non-Hodgkin's Lymphoma: Dec-12-2006 — Treatment side-effects are moderate and consistent for patients treated with radioimmunotherapy (RIT) for relapsed or refractory NHL: study including RPCI.
Chronic Lymphocytic Leukemia Patients Respond to Lenalidomide: Dec-12-2006 — Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia (CLL) or who have chemo-resistant disease may have a new option for therapy, according to a phase II study conducted at RPCI.
Genetics Predicts Toxicity Following Blood and Marrow Transplantation: Dec-11-2006 — The outlook for cancer patients treated with BMT for fatal blood cancers is much brighter today based on research conducted at RPCI: Theresa E. Hahn, PhD, Department of Medicine.
Progress in Common Hematologic Cancers: Dec-11-2006 — Results of two clinical trials conducted at RPCI point to an improved outlook for patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) who have relapsed or whose disease no longer responds to standard therapies.
Faculty Members Invited to Participate in National Meeting: Dec-11-2006 — Three members of the faculty of the Department of Medicine at Roswell Park Cancer Institute have been invited to participate in special sessions at the 48th Annual Meeting & Exposition of the American Society of Hematology (ASH), December 9-12, in Orlando, FL.
Lenalidomide Enhances Effects of Monoclonal Antibodies in B-Cell Lymphoma: Dec-10-2006 — Combining a new immunomodulating cancer drug, lenalidomide, with monoclonal antibodies - galiximab (anti-CD80 antibody) and campath (anti-CD52 antibody) - appears to have significant anticancer activity for patients with B-cell lymphoma: RPCI study.
New Hope for Patients With Chronic Lymphocytic Leukemia: Dec-04-2006 — Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia (CLL) or disease that no longer responds to chemotherapy have experienced a major response to therapy according to RPCI phase II study.
New Contract In Place for Univera & RPCI: Nov-28-2006 — Univera Healthcare and Roswell Park Cancer Institute have reached an agreement on a new, multi-year provider contract that covers all services offered by Roswell Park. The contract takes effect January 1, 2007.
Roswell Park Among Top in the Nation in NIH Awards: Nov-21-2006 — RPCI is ranked 13th among the nation's 118 independent academic hospitals for National Institutes of Health (NIH) funding in fiscal year 2005, according to the federal agency's latest figures.
Roswell Park Offers Center for Women at High Risk for Breast Cancer: Nov-10-2006 — If you are a woman who has a family history of breast cancer or other risk factors that increase your risk, you may be interested in evaluation at the newly opened Breast Cancer Risk Assessment and Prevention Program at RPCI.
Composite NanoDevices in Imaging & Nano Radiation Therapy: Nov-06-2006 — Principles and mechanisms of nanotechnology will be examined by Mohamed K. Khan, MD, PhD, NanoBiotechnology Center, RPCI, during the 48th annual meeting of ASTRO.
New Clinical Research Initiative at RPCI Will Expand Patient Participation Up to Three-Fold: Oct-30-2006 — With less than five percent of all cancer patients in the country participating in clinical research studies, RPCI has unveiled a major initiative that promises to change that profile in New York State.
Blood and Platelet Donors Needed at Roswell Park: Oct-16-2006 — Recent weather events have created an urgent need for blood and platelet donations at Roswell Park Cancer Institute. Cancer patients require blood and blood platelet donations almost every day as part of their care.
Independent Health and Roswell Park Agree on New Contract: Oct-05-2006 — Independent Health and RPCI have reached agreement on a new, multi-year provider contract...
Special Program Designed for Women with Recurrent Breast Cancer: Oct-02-2006 — A special program is being planned for women with recurrent or metastatic breast cancer.
Molecular & Genetic Alterations May Explain Racial Disparity in Breast Cancer: Sep-25-2006 — Conclusions of literature review by a research team at Roswell Park.
Blood Donors Needed: Jul-07-2006 — A donation of platelets, called plateletpheresis, is similar to donating whole blood. The simple, safe process takes approximately 90 minutes. Blood is removed from the donor and passed through a machine that separates and collects the platelets. The donor’s body quickly replaces the removed platelets.
Roswell Park Offers Oncology Update: Jun-23-2006 — Roswell Park Cancer Institute (RPCI) will host "Highlights from ASCO 2006," Saturday, July 15, 7:30 am - 12:45, in the Hilleboe Auditorium, Research Studies Center, RPCI, Elm & Carlton Streets.
Roswell Park Awards American Cancer Society Grants: Jun-14-2006 — RPCI has awarded two $20,000 Institutional Research Grants (IRGs) to Naoyuki Saito, MD, PhD, Department of Radiation Medicine, and Ivan Still, PhD, Department of Cancer Genetics.
RPCI Presents at American Society of Clinical Oncology: Jun-04-2006 — Researchers from RPCI joined more than 25,000 cancer specialists from around the world at the annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the latest advances in cancer care, treatment, prevention and survivorship.
Electronic Health Record Goes Live at Roswell Park: May-31-2006 — The first components of a fully integrated electronic health record system have "gone live" at Roswell Park Cancer Institute (RPCI); beginning a process that will significantly improve in the way the Institute manages patient records.
Oncology Nurses Help Identify/Manage New Side Effect of Leukemia Agent: May-02-2006 — A study led by Kena Miller, FNP (RPCI) has identified a novel side effect and created a strategy for management of symptoms associated with a treatment regimen for patients diagnosed with chronic lymphocytic leukemia.
Patients Respond to New Treatment Regimen for Multiple Myeloma: May-02-2006 — A novel drug combination given on a unique schedule has improved the overall and complete response rates among patients with multiple myeloma, according to a study led by Kena Miller, FNP, Dept. of Nursing (RPCI).
Patient Screening Helps to Provide Better, Faster Care: May-02-2006 — Screening of inter-hospital transfers by oncology nurse case managers enhances the capacity and maximizes resource utilization at freestanding National Cancer Institute (NCI)-designated comprehensive cancer centers.
Bladder Cancer Robotic-Assisted Surgery Now Available at Roswell Park Cancer Institute: Feb-10-2006 — RPCI is the first facility in Buffalo and among the first centers in the country to offer state-of-the-art robotic-assisted surgery to patients with bladder cancer. The pioneering technique offers these patients a less invasive treatment option that has several potential advantages over traditional open surgery.
Roswell Park Contributes to National Study for Advanced Ovarian Cancer: Jan-05-2006 — A post-surgical combination chemotherapy method that uses two methods of administration extends overall survival for women with advanced ovarian cancer by approximately one year, according to an announcement by the National Cancer Institute (NCI). Shashikant Lele, MD, Chair of the Department of Gynecologic Oncology, RPCI, is the principal investigator at RPCI for the Gynecologic Oncology Group and a major contributor to the clinical trial effort.